Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

NCT00017199

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

NCT00017147

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States

Banner Good Samaritan Medical Center Phoenix, Arizona, United States

CCOP - Western Regional, Arizona Phoenix, Arizona, United States

St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View all 163 locations

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

NCT00028496

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

NCT00006243

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

BMS-247550 in Treating Patients With Stage IV Melanoma

NCT00036764

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: New York University Clinical Cancer Center New York, United States

View Trial Details

Completed

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

NCT00003023

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +12 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

NCT00354913

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

NCT00037011

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

NCT00072345

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions